{"id":8377,"date":"2015-05-05T22:05:50","date_gmt":"2015-05-05T21:05:50","guid":{"rendered":"https:\/\/mileon.wordpress.com\/?p=8377"},"modified":"2015-05-05T22:05:50","modified_gmt":"2015-05-05T21:05:50","slug":"sesiones-de-residentes-the-new-england-journal-of-medicine","status":"publish","type":"post","link":"https:\/\/www.icscyl.com\/mileon\/residentes\/2015-05-05\/sesiones-de-residentes-the-new-england-journal-of-medicine\/","title":{"rendered":"Sesiones de residentes: The New England Journal of Medicine."},"content":{"rendered":"<p style=\"text-align:justify;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-8089\" src=\"https:\/\/mileon.files.wordpress.com\/2015\/02\/c3adndice.jpg\" alt=\"\u00edndice\" width=\"152\" height=\"152\" \/>El 4 de mayo de 2015 el Dr. Joaqu\u00edn Garc\u00eda Llorente (R4 MI) revis\u00f3 en la sesi\u00f3n de los lunes tres art\u00edculos del NEJM de forma cr\u00edtica, son:<\/p>\n<ul style=\"text-align:justify;\">\n<li style=\"text-align:justify;\"><em>Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.<\/em><\/li>\n<li><em>Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.<\/em><\/li>\n<li><em>Systemic inflammatory response syndrome criteria in defining severe sepsis.<\/em><\/li>\n<\/ul>\n<p style=\"text-align:justify;\">Su presentaci\u00f3n se puede descargar en el siguiente\u00a0<a href=\"https:\/\/drive.google.com\/file\/d\/0BxXYCqMXR4ZaY2lybGFCSXhBTjg\/view?usp=sharing\">enlace.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El 4 de mayo de 2015 el Dr. Joaqu\u00edn Garc\u00eda Llorente (R4 MI) revis\u00f3 en la sesi\u00f3n de los lunes tres art\u00edculos del NEJM de forma cr\u00edtica, son: Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. Systemic inflammatory response syndrome criteria [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[721],"tags":[],"class_list":["post-8377","post","type-post","status-publish","format-standard","hentry","category-residentes"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/8377","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/comments?post=8377"}],"version-history":[{"count":0,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/posts\/8377\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/media?parent=8377"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/categories?post=8377"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.icscyl.com\/mileon\/wp-json\/wp\/v2\/tags?post=8377"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}